I
Igor Paron
Researcher at Max Planck Society
Publications - 10
Citations - 6317
Igor Paron is an academic researcher from Max Planck Society. The author has contributed to research in topics: Proteome & Proteomics. The author has an hindex of 8, co-authored 10 publications receiving 4506 citations. Previous affiliations of Igor Paron include Technische Universität München.
Papers
More filters
Journal ArticleDOI
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
TL;DR: A new intensity determination and normalization procedure called MaxLFQ is developed that is fully compatible with any peptide or protein separation prior to LC-MS analysis, which accurately detects the mixing ratio over the entire protein expression range, with greater precision for abundant proteins.
Journal ArticleDOI
Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells.
TL;DR: An in-StageTip method for performing sample processing, from cell lysis through elution of purified peptides, in a single, enclosed volume, and observes excellent quantitative reproducibility between replicates.
Journal ArticleDOI
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
Alexey Stukalov,Virginie Girault,Vincent Grass,Ozge Karayel,Valter Bergant,Christian Urban,Darya A. Haas,Yiqi Huang,Lila Oubraham,Anqi Wang,M. Sabri Hamad,Antonio Piras,Fynn M. Hansen,Maria C. Tanzer,Igor Paron,Luca Zinzula,Thomas Engleitner,Maria Reinecke,Maria Reinecke,Teresa M. Lavacca,Rosina Ehmann,Roman Wölfel,Jörg Jores,Bernhard Kuster,Bernhard Kuster,Ulrike Protzer,Roland Rad,John Ziebuhr,Volker Thiel,Pietro Scaturro,Pietro Scaturro,Matthias Mann,Andreas Pichlmair +32 more
TL;DR: A concurrent multi-omics study of SARS CoV-2 and SARS-CoV was conducted in this article, where the authors profiled the interactomes of both viruses, as well as their influence on the transcriptome, proteome, ubiquitinome and phosphoproteome of a lung derived human cell line.
Posted ContentDOI
Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV
Alexey Stukalov,Virginie Girault,Vincent Grass,Ozge Karayel,Valter Bergant,Christian Urban,Darya A. Haas,Yiqi Huang,Lila Oubraham,Anqi Wang,Sabri M. Hamad,Antonio Piras,Fynn M. Hansen,Maria C. Tanzer,Igor Paron,Luca Zinzula,Luca Zinzula,Thomas Engleitner,Maria Reinecke,Maria Reinecke,Teresa M. Lavacca,Rosina Ehmann,Roman Wölfel,Jörg Jores,Bernhard Kuster,Bernhard Kuster,Ulrike Protzer,Roland Rad,John Ziebuhr,Volker Thiel,Pietro Scaturro,Pietro Scaturro,Matthias Mann,Andreas Pichlmair +33 more
TL;DR: The TGF-β pathway, known for its involvement in tissue fibrosis, was specifically dysregulated by Sars-CoV-2 ORF8 and autophagy by SARS-CoVs ORF3, and was identified as a hotspot that can be targeted by existing drugs and it can guide rational design of virus- and host-directed therapies.
Journal ArticleDOI
A novel LC system embeds analytes in pre-formed gradients for rapid, ultra-robust proteomics
Nicolai Bache,Philipp E. Geyer,Philipp E. Geyer,Dorte B. Bekker-Jensen,Ole Hoerning,Lasse Gaarde Falkenby,Peter V. Treit,Sophia Doll,Igor Paron,Johannes Müller,Florian Meier,Jesper V. Olsen,Ole Vorm,Matthias Mann,Matthias Mann +14 more
TL;DR: The new system - termed Evosep One - analyzes samples in an extremely robust and high throughput manner, without sacrificing in depth proteomics coverage, while maintaining the sensitivity of current nano-flow LC systems.